Cannuflow Competitors and Similar CompaniesClear all

Cannuflow's competitors and similar companies include Exactech, Haemonetics and Orthofix.

	Cannuflow Cannuflow is a company that develops and markets medical devices that help healthcare professionals regulate fluid management performance during arthroscopic surgery.	Exactech Exactech is a manufacturer of implants and smart technologies for joint replacement.	Haemonetics Haemonetics is a provider of medical products and solutions.	Orthofix Orthofix Medical (formerly Orthofix International) is a company that provides specialized orthopedic solutions and a surgical navigation system.
Founding Date	Founding Date 2002	Founding Date 1985	Founding Date 1971	Founding Date 1980
Type	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare medical devices medtech surgical solutions
Locations	Locations Campbell, US HQ Scotts Valley, US	Locations Gainesville, US HQ Castle Hill, AU Mérignac, FR Meylan, FR Kiel, DE Brescia, IT Tokyo, JP see more	Locations Boston, US HQ North Ryde, AU Edmonton, CA Québec, CA Beijing, CN Shanghai, CN Brno, CZ see more	Locations Lewisville, US HQ Barangaroo, AU Sao Paulo, BR Toronto, CA Arcueil, FR Paris, FR Laichingen, DE see more
Employees	Employees N/A	Employees 9891% decrease	Employees 3,65721% increase	Employees 1,63450% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.7 b	Valuation ($) 624.5 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.3b (FY, 2026)	Revenue (est.) $822.3m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $546.4m (FY, 2026)	Cost of goods $256.3m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $787.6m (FY, 2026)	Gross profit $566m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $97.3m (FY, 2026)	Net income ($92.2m) (FY, 2025)